ATE493408T1 - Antiinfektiöse mittel - Google Patents
Antiinfektiöse mittelInfo
- Publication number
- ATE493408T1 ATE493408T1 AT03768559T AT03768559T ATE493408T1 AT E493408 T1 ATE493408 T1 AT E493408T1 AT 03768559 T AT03768559 T AT 03768559T AT 03768559 T AT03768559 T AT 03768559T AT E493408 T1 ATE493408 T1 AT E493408T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- hcv
- inhibiting
- processes
- antinifective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/285,714 US20040097492A1 (en) | 2002-11-01 | 2002-11-01 | Anti-infective agents |
US10/410,853 US20040087577A1 (en) | 2002-11-01 | 2003-04-10 | Anti-infective agents |
US10/625,121 US20040162285A1 (en) | 2002-11-01 | 2003-07-23 | Anti-infective agents |
US10/679,881 US20050075331A1 (en) | 2003-10-06 | 2003-10-06 | Anti-infective agents |
PCT/US2003/034707 WO2004041818A1 (en) | 2002-11-01 | 2003-10-31 | Anti-infective agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE493408T1 true ATE493408T1 (de) | 2011-01-15 |
Family
ID=43426110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03768559T ATE493408T1 (de) | 2002-11-01 | 2003-10-31 | Antiinfektiöse mittel |
Country Status (6)
Country | Link |
---|---|
JP (2) | JP4738172B2 (de) |
AT (1) | ATE493408T1 (de) |
DE (1) | DE60335564D1 (de) |
DK (1) | DK1560827T3 (de) |
PT (1) | PT1560827E (de) |
SI (1) | SI1560827T1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA100120C2 (en) | 2007-04-03 | 2012-11-26 | Анадис Фармасьютикалз, Инк. | 5,6-dihydro-1h-pyridin-2-one compounds |
GB0800855D0 (en) * | 2008-01-17 | 2008-02-27 | Syngenta Ltd | Herbicidal compounds |
EP2283002A2 (de) * | 2008-04-15 | 2011-02-16 | Intermune, Inc. | Neue replikationshemmer des hepatitis-c-virus |
EA201100661A1 (ru) * | 2008-10-29 | 2011-12-30 | Басф Се | Замещенные пиридины с гербицидным действием |
KR20110122874A (ko) * | 2009-03-06 | 2011-11-11 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 항바이러스 화합물 |
JP2013525368A (ja) * | 2010-04-23 | 2013-06-20 | キネタ・インコーポレイテツド | 抗ウイルス性化合物 |
US8815847B2 (en) * | 2011-06-07 | 2014-08-26 | Anadys Pharmaceuticals, Inc. | [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040034041A1 (en) * | 2000-05-10 | 2004-02-19 | Dashyant Dhanak | Novel anti-infectives |
AR036081A1 (es) * | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
WO2003059356A2 (en) * | 2001-10-30 | 2003-07-24 | Smithkline Beecham Corporation | Novel anti-infectives |
-
2003
- 2003-10-31 DK DK03768559.1T patent/DK1560827T3/da active
- 2003-10-31 PT PT03768559T patent/PT1560827E/pt unknown
- 2003-10-31 DE DE60335564T patent/DE60335564D1/de not_active Expired - Lifetime
- 2003-10-31 JP JP2005502238A patent/JP4738172B2/ja not_active Expired - Fee Related
- 2003-10-31 SI SI200331953T patent/SI1560827T1/sl unknown
- 2003-10-31 AT AT03768559T patent/ATE493408T1/de active
-
2011
- 2011-02-18 JP JP2011033491A patent/JP5250649B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
SI1560827T1 (sl) | 2011-04-29 |
JP2011144183A (ja) | 2011-07-28 |
DK1560827T3 (da) | 2011-04-18 |
JP5250649B2 (ja) | 2013-07-31 |
PT1560827E (pt) | 2011-03-17 |
DE60335564D1 (de) | 2011-02-10 |
JP2006509042A (ja) | 2006-03-16 |
JP4738172B2 (ja) | 2011-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2361913A8 (de) | Antiinfektiöse Mittel | |
WO2007076034A3 (en) | Anti-viral compounds | |
WO2007081517A8 (en) | Anti-viral compounds | |
BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
ID27787A (id) | Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan | |
IS8448A (is) | Lifrarbólgu C-veirutálmar | |
BR0305259A (pt) | Inibidores de hcv ns5b polimerase | |
CO5630024A2 (es) | Compuestos inhibidores de la hepatitis c | |
UY35542A (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
BR0110023A (pt) | Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite | |
EA200900156A1 (ru) | Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе | |
EE05709B1 (et) | Nukleosiidhend, seda sisaldav farmatseutiline kompositsioon ning hendi kasutamine viiruse RNA-s?ltuva RNA polmeraasi inhibiitorina toimiva ravimi valmistamiseks | |
WO2004009020A3 (en) | Pyrrolopyrimidine thionucleoside analogs as antivirals | |
IS7533A (is) | Lifrarbólgu C-veirutálmar | |
HK1122292A1 (en) | Anti-viral compounds | |
WO2001077091A3 (en) | Ns5b hcv polymerase inhibitors | |
BRPI0515596A (pt) | composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero | |
MY140680A (en) | Hepatitis c virus inhibitors | |
BRPI0415883A (pt) | compostos e composições de nucleosìdeo para o tratamento de infecções virais | |
WO2005054430A3 (en) | Hepatitis c virus inhibitors | |
DE60319820D1 (de) | Pyrazoloä1,5-aüpyrimidin-verbindungen als antivirale agentien | |
HK1100164A1 (en) | Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of hcv replication | |
TW200612898A (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same | |
WO2004110351A3 (en) | Heterocyclic compounds for treating hepatitis c virus | |
ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1560827 Country of ref document: EP |